Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.
Will Spooren
Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche
From this contributor
Questions for Will Spooren: Paving a path to autism drugs
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
Questions for Will Spooren: Paving a path to autism drugs
By
Ingrid Wickelgren
13 October 2015 | 6 min read
Explore more from The Transmitter
Bringing African ancestry into cellular neuroscience
Two independent teams in Africa are developing stem cell lines and organoids from local populations to explore neurodevelopmental and neurodegenerative conditions.
Bringing African ancestry into cellular neuroscience
Two independent teams in Africa are developing stem cell lines and organoids from local populations to explore neurodevelopmental and neurodegenerative conditions.
By
Lauren Schenkman
14 January 2026 | 7 min read
Tomaso Poggio on his quest for theories to explain the fundamental learning abilities of brains and machines
Thus far, engineering has outpaced theory in the science of intelligence. But Poggio is hopeful that theories can catch up.
Tomaso Poggio on his quest for theories to explain the fundamental learning abilities of brains and machines
Thus far, engineering has outpaced theory in the science of intelligence. But Poggio is hopeful that theories can catch up.
By
Paul Middlebrooks
14 January 2026 | 1 min read
Alzheimer’s disease and autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 12 January.
Alzheimer’s disease and autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 12 January.
By
Jill Adams
13 January 2026 | 2 min read